Nautic Partners LLC has acquired KabaFusion for an undisclosed amount, marking a significant change in ownership for the national home and alternative site infusion therapy provider. The transaction sees the private equity firm add KabaFusion to its portfolio, signaling a strategic investment in the specialized healthcare sector.
KabaFusion is a national company renowned for its comprehensive range of infusion therapy services. The company employs a multidisciplinary team approach to ensure continuity of care for patients transitioning from hospital to home. It prioritizes patient care, specializing in intravenous immune globulin (IVIG) therapy and other complex specialty pharmacy needs, with pharmacists and nurses available 24 hours a day. KabaFusion was founded by experts in IVIG infusion and operates facilities conveniently placed throughout the country.
This acquisition is strategic for Nautic Partners as it expands its footprint within the growing home healthcare market, particularly in specialized infusion services. The purchase allows Nautic to leverage KabaFusion's established national network, clinical expertise, and patient-focused model. Expected synergies include operational enhancements and accelerated growth for KabaFusion through Nautic's investment capabilities and strategic guidance, aiming to further strengthen service delivery and patient outcomes.
The combined entity is expected to focus on continuing KabaFusion's mission of providing high-quality, patient-centric infusion care. This ownership change is anticipated to support KabaFusion's expansion and its commitment to proactive engagement with patients, healthcare practitioners, and payers, further solidifying its position in the specialized infusion therapy landscape.